Nucletron Launches Russian Website

January 10 2005  

Veenendaal, The Netherlands January 3, 2005 – Effective December 2004, Nucletron has launched a website localized for the Russian market.


The effort for localization is spurred by Nucletron’s desire for transparency and for adaptation to local market requirements. Patient care is provided, and equipment sourced and used, almost exclusively in the local language in Russia.


“Nucletron’s website is an important information exchange on the latest alternatives and improvements in patient care, methods of cancer treatment and care management,” says Mark Adam, Vice President of Marketing. “Information is dedicated not only to our customers who specialise in patient care and manage the care process, but also to our other stakeholders, notably patients, their relatives, and carers. Moreover, sector thought leaders such as medical research specialists, consultants, and medical students are also interested in the content.”  


Adds Mark Adam, “As Internet is a global communication channel, we have taken the opportunity to empower non English speakers with the knowledge they seek on Nucletron’s website.”


With localization, Nucletron is confident that its Russian speaking visitors will find its website an invaluable source of information - from the latest developments in brachytherapy and integrated software solutions for oncology, to further improvements in patient care.


Nucletron’s website is now available in six major languages including English, German, French, Spanish and Chinese.



About Nucletron B.V.

Nucletron is a global leader in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment. Nucletron B.V. has particular expertise in treatment planning systems, brachytherapy, simulation, integrated software solutions for oncology, and comprehensive support, professional education and services. The company has over 20 offices worldwide, including its corporate headquarters in Veenendaal, The Netherlands. For more information on Nucletron, please visit: http://www.nucletron.com/.


Nucletron B.V. is a subsidiary of Delft Instruments N.V. Delft Instruments is the holding company of an international group of companies. It is holding a leading position in their respective markets with high quality, high technology products and services. Delft Instruments employs some 1,200 people and reported net profit of EUR 10.4 million on turnover of EUR 237 million in 2003. For more information on Delft Instruments, visit:  http://www.delftinstruments.com/



For further information: